Search Results - "Mian, Mohammad A. H."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most? by Keruakous, Amany R, Walker, Laura, Denlinger, Molly, Mian, Mohammad A H, Bradshaw, Danielle, Kota, Vamsi K, Jillella, Anand P

    Published in Hematology reports (12-07-2024)
    “…High-dose chemotherapy (HD-CHT) followed by autologous stem cell transplantation (ASCT) remains the gold standard for eligible multiple myeloma (MM) patients,…”
    Get full text
    Journal Article
  3. 3

    Purpura Fulminans : A Case Series Managed at a Regional Burn Center by HASSAN, Zaheed, MULLINS, Robert F, FRIEDMAN, Bruce C, SHAVER, Joseph R, ALAM, Badrul, MIAN, Mohammad A. H

    Published in Journal of burn care & research (01-03-2008)
    “…Purpura fulminans (PF) is a protein C deficiency disease process with a high case fatality rate; however, overall incidence of the disease remains relatively…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates by Friedman, Bruce C, Mian, Mohammad A H, Mullins, Robert F, Hassan, Zaheed, Shaver, Joseph R, Johnston, Krystal K

    Published in Journal of burn care & research (01-07-2015)
    “…The objective of this study is to determine the catheter-related bloodstream infection (CRBSI) rate in a severely burned patient population, many of whom…”
    Get full text
    Journal Article
  6. 6

    Treating necrotizing fasciitis with or without hyperbaric oxygen therapy by Hassan, Zaheed, Mullins, Robert F, Friedman, Bruce C, Shaver, Joseph R, Brandigi, Claus, Alam, Badrul, Mian, Mohammad A H

    Published in Undersea & hyperbaric medicine (01-03-2010)
    “…There is not enough clinical data to support the benefit of adjuvant HBO2 therapy for necrotizing fasciitis (NF). We retrospectively reviewed our 67 NF cases…”
    Get more information
    Journal Article
  7. 7

    The Increased Use of Diagnostic Studies over Time in Acute Myelogenous Leukemia Patients by Okereke, Chijioke, Fox, Ashley D, Le, Thuy, Abbagoni, Sujith, Jillella, Anand P, Bryan, Locke J., Anwar, Tahsin, Mian, Mohammad A.H., Kota, Vamsi

    Published in Blood (23-11-2021)
    “…Background: Guidelines on the clinical management of certain disease processes assists providers in their decision making and in some cases reduce the amount…”
    Get full text
    Journal Article
  8. 8

    Rates of Neutropenic Fever in Patients with Hematologic Malignant Diseases with Central Venous Access by Abbagoni, Sujith, Malik, Sarah, Fox, Ashley D, Mian, Mohammad A.H., Anwar, Tahsin, Bradshaw, Danielle, Bryan, Locke J., Jillella, Anand P, Kolhe, Ravindra, Savage, Natasha M., Padala, Sandeep, Kota, Vamsi

    Published in Blood (23-11-2021)
    “…Background: Patients who are diagnosed with hematologic malignant diseases (HMD) almost invariably receive placement of central venous catheters (CVCs),…”
    Get full text
    Journal Article
  9. 9

    Serum Albumin As a Prognostic Factor for Overall Survival at 6-Months in Acute Myeloid Leukemia (AML) by Fox, Ashley D, Okereke, Chijioke, Le, Thuy, Jillella, Anand P, Bryan, Locke J., Anwar, Tahsin, Mian, Mohammad A.H., Bradshaw, Danielle, Kolhe, Ravindra, Savage, Natasha M., Ajebo, Germame, Padala, Sandeep, Abbagoni, Sujith, Kota, Vamsi

    Published in Blood (23-11-2021)
    “…Introduction: The role of serum albumin as a prognostic factor has been well established in various medical conditions including some hematologic malignancies…”
    Get full text
    Journal Article
  10. 10

    Central Line Associated Bloodstream Infection Rate Among Hematologic Malignant Patients Who Received Antimicrobial Prophylaxis in the Inpatient Setting by Abbagoni, Sujith, Le, Thuy, Bryan, Locke J., Mian, Mohammad A.H., Bradshaw, Danielle, Fox, Ashley D, Jillella, Anand P, Okereke, Chijioke, Kolhe, Ravindra, Savage, Natasha M., Kota, Vamsi

    Published in Blood (23-11-2021)
    “…Introduction: Patients with hematological malignancies are at increased risk of infections which leads to increased morbidity and mortality. Particularly, they…”
    Get full text
    Journal Article
  11. 11

    Elevated Ferritin Prior to Collection and Mobilization May Predict Low Stem Cell Yield by Weeks, Charles Joseph, Bradshaw, Danielle, Mian, Mohammad A H, Shah, Anvay, Kim, Katherine J, Abbagoni, Sujith, Jillella, Anand P, Kota, Vamsi

    Published in Transplantation and cellular therapy (01-02-2024)
    “…Bone marrow transplantation requires collecting an adequate number of hematopoietic stem cells to ensure successful engraftment. Ferritin, a key iron storage…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Characteristics of Multiple Myeloma Patients on Dialysis Who Receive Autologous Stem Cell Transplant by Pavkov, Isabela L, Bradshaw, Danielle, Mian, Mohammad AH, Kota, Vamsi

    Published in Transplantation and cellular therapy (01-02-2024)
    “…Renal impairment is part of the natural progression of multiple myeloma (MM); as such up to 40% of MM patients present with some degree of renal disease at…”
    Get full text
    Journal Article
  15. 15

    Blood Product Support in Multiple Myeloma Patients Undergoing Autologous Bone Marrow Transplantation May Predict Improved Outcome by Pavkov, Isabela L, Shoukier, Mahran, Mian, Mohammad AH, Stokes, Michael, Reategui, Yazmin, Nain, Priyanshu, Bradshaw, Danielle, Jillella, Anand, Kota, Vamsi

    Published in Transplantation and cellular therapy (01-02-2024)
    “…Patients with multiple myeloma (MM) who received autologous bone marrow transplantation (ABMT) may require transfusion of packed red blood cells (pRBCs) and…”
    Get full text
    Journal Article